Bipolar affective disorder is a common neuropsychiatric disorder. Although its
neurobiological underpinnings are incompletely understood, the dopamine hypothesis has …

Neurological disorders have emerged as a predominant healthcare concern in recent years
due to their severe consequences on quality of life and prevalence throughout the world …

Background The current societal costs of bipolar I disorder (BDI) have not been
comprehensively characterized in the United States, as previous studies are based on data …

El trastorno bipolar es un trastorno crónico y recurrente que se caracteriza por fluctuaciones
patológicas del estado del ánimo. Las fases de la enfermedad incluyen episodios …

Bipolar disorder (BD) is a multifactorial illness thought to result from an interaction between
genetic susceptibility and environmental stimuli. Epigenetic mechanisms, including DNA …

Background Bipolar disorder refers to a group of chronic psychiatric disorders of mood and
energy levels. While dramatic psychiatric symptoms dominate the acute phase of the …

Modern antipsychotic drugs are employed increasingly in the treatment of mood disorders
as well as psychoses, stimulating interest in their possible contributions to altering suicidal …

Neuropsychiatric diseases are a group of disorders that cause significant morbidity and
disability. The symptoms of psychiatric disorders include anxiety, depression, eating …

Abstract Purpose of Review The present review will provide an overview of the
neurobiology, epidemiology, clinical impact, and treatment of cannabis use disorder (CUD) …

Background Rates of response and remission are measures that endorse the clinical
significance of treatment. Cariprazine is FDA approved for the acute treatment of …